-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

905.O2.6 905. Outcomes Research-Lymphoid Malignancies: Lymphoma/CLL Real-World Data

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Lymphoid Leukemias, CLL, Lymphomas, Clinical Research, Clinically Relevant, Diseases, Lymphoid Malignancies, Clinical Practice (e.g. Guidelines, Health Outcomes and Services, and Survivorship, Value; etc.)
Saturday, December 11, 2021: 12:00 PM-1:30 PM
Sidney Marcus Auditorium, Level 4, Building A (Georgia World Congress Center)
Moderators:
Narendranath Epperla, MD, MS, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA and Matthew C. Cheung, MD, MSc, Sunnybrook Odette Cancer Centre
Disclosures:
Epperla: Verastem: Speakers Bureau; Beigene: Speakers Bureau; Karyopharm: Other: Ad Board; Genzyme: Honoraria.
This session focuses on outcomes in lymphoma/CLL including impact of specific co-morbidities, treatment modalities as well as outcomes related to COVID-19 among these patients
12:00 PM

Katharine Louise Lewis, BMBS, FRCPath, MRCPath1,2, Lasse H. Jakobsen, MSc, PhD3*, Diego Villa, MD, MPH, FRCPC4, Sabela Bobillo, MD, PhD5*, Karin Ekstroem Smedby, MD, PhD6*, Kerry J. Savage, MD, MSc, FRCPC4, Toby A. Eyre7*, Kate Cwynarski8*, Paris L Caporn, BBiomedSc9*, Joan Van Zyl, BBioMedSc9*, Magdalena Klanova, MD, PhD10,11*, Marek Trněný, MD, Prof12,13, Robert Puckrin, MD FRCPC14*, Douglas A. Stewart, MD, FRCPC15,16, Mark J Bishton, MB ChB, PhD17*, Christopher P. Fox17*, Aung M Tun, MD18*, Gita Thanarajasingam, MD18, Faouzi Djebbari19*, Erel Joffe, MD, MSc20, Sandra Eloranta, PhD21*, Sara Harrysson, MD21*, Laurie H. Sehn, MD22, Seth M Maliske, MD23, Kittika Poonsombudlert, MD24, Xiao Guo, MD25*, Greg Hapgood, MD, PhD25*, Kate Manos26*, Eliza Hawkes, MD27, Jahanzaib Khwaja28*, Adrian Minson, MBBS29*, Michael Dickinson, MBBS29,30, Andreas Kiesbye Oevlisen, MD, PhD3*, Gareth P Gregory, MBBS PhD31, Michael Gilbertson, MBBS (Hons) FRACP FRCPA32*, Isaac T Streit, MSc4*, Hamish W Scott33*, Matthew Ku34,35, Sanjay de Mel, BSc (Hons) BM (Hons), MRCP(UK), FRCPath36*, Kar Ying Yong, MBBS, MRCP37*, Liu Xin, M.A. in Counselling and Guidance, MSc in Biomedical Engineering37*, Mridula Mokoonlall, MBBS38*, Dipti Talaulikar, PhD, FRACP, FRCPA, MBBS38, Nicholas L McVilly, MBBS39*, Anna Johnston, MBBS, FRACP, FRCPA39,40*, Matthew J Brunner, MD41*, Priyanka A Pophali, MD42,43, Matthew J. Maurer, MS, DMSc44*, Tarec Christoffer El-Galaly, MD3 and Chan Yoon Cheah2,9,45

1Department of Haematology, Sir Charles Gairdner Hospital, West Leederville, WEA, Australia
2Department of Haematology, Sir Charles Gairdner Hospital, Perth, WA, Australia
3Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark
4BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
5Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
6Department of Medicine Solna, Division of clinical epidemiology, Karolinska Institutet, Stockholm, Stockholm, Sweden
7Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Old Road, United Kingdom
8Department of Haematology, University College London Hospital NHS Foundation Trust, London, United Kingdom
9University of Western Australia, Perth, WA, Australia
101st Internal Department - Department of Haematology, General University Hospital, Prague, Czech Republic
11First Deptartment of Internal Medicine - Hematology, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
12First Dept. of Medicine- Hematology, Charles University General Hospital and First Faculty of Medicine, Praha 2, Czech Republic
13Urologicka Klinika, Vseobecna Fakultni Nemocnice, Interni Klinika—Klinika Hematologie, Prague, Czech Republic
14Department of Oncology, University of Calgary, Calgary, AB, Canada
15Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada
16Tom Baker Cancer Centre, Calgary, AB, Canada
17Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
18Mayo Clinic, Division of Hematology, Rochester, MN, USA, Rochester, MN
19Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
20Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
21Department of Medicine Solna, Division of clinical epidemiology, Karolinska Institutet, Stockholm, Sweden
22Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
23Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospital and Clinics, Iowa City, IA
24Holden Comprehensive Cancer Center, University of Iowa Hospital and Clinics, Iowa city, IA
25Princess Alexandra Hospital, Brisbane, QLD, Australia
26Department of Clinical Haematology, Austin Health, Melbourne, Australia
27Department of Clinical Haematology, Austin Health, Heidelberg, VIC, Australia
28Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
29Department of Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
30Royal Melbourne Hospital, Melbourne, Australia
31Monash Haematology, Monash Health, Melbourne, Australia
32Department of Haematology, Monash Health, Melbourne, Australia
33Department of Haematology, St Vincent’s Hospital, Melbourne, Australia, Melbourne, Australia
34Department of Haematology, St Vincent’s Hospital and University of Melbourne, Melbourne, Australia
35University of Melbourne, Melbourne, Australia
36Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore, Singapore
37National University Health System, Kent Ridge, Singapore
38Department of Haematology, The Canberra Hospital, Canberra, Australia
39Department of Haematology, Royal Hobart Hospital, Hobart, Australia
40University of Tasmania, Hobart, Australia
41Division of Hematology, University of Wisconsin, Madison, Madison, WI
42Division of Hematology, Department of Medicine, University of Wisconsin- Carbone Cancer Center, Madison, WI
43Carbone Cancer Center, Madison
44Mayo Clinic, Division of Clinical Trials and Biostatistics, Rochester, MN, USA, Rochester, MN
45Linear Clinical Research, Perth, Australia

12:15 PM

Mengyang Di, MD, PhD1,2, Can Cui, MD3*, Shalin K. Kothari, MD4, Amer M. Zeidan, MD2,4, Nikolai Podoltsev, MD, PhD2,4, Natalia Neparidze, MD2,4, Rory M. Shallis, MD2,4, Rong Wang, PhD2,5*, Xiaomei Ma, PhD2,6* and Scott F. Huntington, MD, MPH2,4

1Department of Hematology/Oncology, Yale University School of Medicine, New Haven, CT
2Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University School of Medicine, New Haven, CT
3Department of Immunobiology, Yale University School of Medicine, New haven, CT
4Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT
5Yale University School of Public Health, New Haven, CT
6Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, CT

12:30 PM

Grzegorz S. Nowakowski, MD1, Dok Hyun Yoon, MD, PhD2*, Patrizia Mondello, MD, PhD, MSc3, Erel Joffe, MD, MSc4*, Isabelle Fleury, MD5, Anthea Peters, MD6, Richard Greil, MD7, Matthew Ku8, Reinhard Marks, MD9*, Kibum Kim, PhD10*, Pier Luigi Zinzani, MD11, Judith Trotman, FRACP12*, Lorenzo Sabatelli, PhD13*, Dan Huang, MSc14*, Eva E. Waltl, PhD14*, Mark Winderlich, PhD14*, Sumeet Ambarkhane, MD14, Nuwan C. Kurukulasuriya, PhD15*, Raul Cordoba, MD, PhD16, Georg Hess, MD17* and Gilles Salles, MD, PhD18

1Division of Hematology, Mayo Clinic, Rochester, MN
2Department of Oncology, Asan Medical Center, Seoul, Korea, Republic of (South)
3Department of Medicine, Memorial Sloan Kettering Cancer Center, Rochester, NY
4Memorial Sloan Kettering Cancer Center, New York, NY
5Maisonneuve-Rosemont Hospital, Institute of Hematology, Oncology and Cell Therapy, Montreal University, Montreal, QC, Canada
6Department of Oncology, University of Alberta, Edmonton, AB, Canada
7Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute-CCCIT, and Cancer Cluster Salzburg, Salzburg, Austria
8Department of Haematology, St Vincent’s Hospital and University of Melbourne, Melbourne, Australia
9University Hospital Freiburg Internal Medicine I, Freiburg im Breisgau, Germany
10University of Utah, Salt Late City, UT
11Institute of Hematology “Seràgnoli” University of Bologna, Bologna, Italy
12Haematology Department, Concord Repatriation General Hospital, University of Sydney, Concord, Australia
13Incyte Biosciences International Sàrl, Morges, Switzerland
14MorphoSys AG, Planegg, Germany
15MorphoSys AG, Boston, MA
16Fundacion Jimenez Diaz University Hospital, Madrid, Spain
17Department of Hematology, Oncology and Pneumology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany
18Memorial Kettering Cancer Center, New York, NY

12:45 PM

Yun Choi, MD1, Jessica Caro, MD1, Xiaochun Li, PhD2*, Arshed Al-Obeidi, MD2*, Sharyn Lynn Kurtz, PA-C, MA3*, Austin I. Kim, MD4, Julie E. Chang, MD5, Adam J. Olszewski, MD6, Adam Zayac, MD7, Andrew Matthews, MD8*, Stefan K. Barta, MD, MRCP, MS8, Suchitra Sundaram, MD9, Francisco J. Hernandez-Ilizaliturri, MD10, Lori A. Leslie, MD11*, Paolo Caimi, MD12, Jordan Carter, MD13, Kevin A. David, MD 14, Andrew M. Evens, DO, MMSc13, Myung Sun Kim, MD15*, Sarah J. Nagle, MD15, Judith Goldberg, ScD16* and Catherine S. Diefenbach, MD1

1Perlmutter Cancer Center, New York University Langone Health, New York, NY
2New York University Langone Health, New York, NY
3Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
4Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA
5University of Wisconsin School of Medicine and Public Health, Madison, WI
6Rhode Island Hospital, Providence, RI
7Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI
8Abramson Cancer Center, Lymphoma Program, University of Pennsylvania, Philadelphia, PA
9Roswell Park Comprehensive Cancer Center, Buffalo, NY
10Department of Hematologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY
11John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
12University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH
13Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
14Cancer Institute of New Jersey, New Brunswick, NJ
15Knight Cancer Institute, Oregon Health and Science University, Portland, OR
16Division of Biostatistics, NYU Grossman School of Medicine, New York, NY

1:00 PM

Lee M Greenberger, PhD1, Larry A Saltzman, MD1*, Jonathon W Senefeld, PhD2*, Patrick W Johnson3*, Louis J DeGennaro, PhD1 and Gwen L Nichols, MD1

1The Leukemia & Lymphoma Society, Rye Brook, NY
2Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN
3Mayo Clinic, Jacksonville, FL

1:15 PM

Joaquin Martinez-Lopez, MD, PhD1*, Javier De La Cruz2*, Rodrigo Gil-Manso3*, Angel Cedillo4*, Adrian Alegre, MD, PhD5, Maria Pilar Llamas Sillero, MD, PhD6*, Rafael F. Duarte, MD, PhD, FRCP7, Víctor Jiménez-Yuste8*, jose Angel Hernandez9*, Mi Kwon10*, Pedro Sanchez Godoy11*, Pilar Martinez-Barranco12*, Blanca Colás Lahuerta13*, Pilar Herrera Puente14*, Lauren Benito15*, Alberto Velasco, MD16*, Arturo Matilla17*, Concha Alaez, MD18*, Rafael Martos19*, Carmen Martínez-Chamorro, MD20*, Keina Quiroz, MD21*, Juan F del Campo22*, Adolfo De La Fuente, MD23*, Maria Regina Herraez24*, Adriana Pascual, MD25*, Elvira Gomez26*, Jaime Perez De Oteyza, MD, PhD27, Elena Ruiz28*, Jose Luis Diez Martin, MD, PhD29* and Julio Garcia-Suarez, PhD30*

1Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Hospital Universitario 12 de Octubre, Complutense University, CNIO, Madrid, Spain
2Hospital Universitario 12 De Octubre, Instituto De Investigación Sanitaria, Madrid, ESP
3Hematology Department, Hospital 12 de Octubre, Madrid, Spain
4Asociacion Madrileña de Hematologia y Hemoterapia, MAdrid, Spain
5Univeritary Hospital La Princesa, Madrid, Madrid, Spain
6Hospital Universitario Fundacion Jimenez Diaz - IISFJD-UAM, Madrid, Spain
7Hematopoietic Transplantation and Hemato-oncology Section, Institut Català d'Oncologia Hospital Duran i Reynals, Madrid, Spain
8Hematology and Hemotherapy Unit, La Paz University Hospital-IdiPAZ, Madrid, Spain
9Hospital Universitario Infanta Leonor, Madrid, Spain
10Department of Hematology, Gregorio Maranon General University Hospital, Madrid, Spain
11Hematology D., Hospital Severo Ochoa Leganes, Madrid, ESP
12Hematology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain
13HOSPITAL ClÍNico SAN CARLOS, MADRID, ESP
14Hematology department, Hospital Ramón y Cajal, Madrid, Spain
15Hematology, Hospital de Getafe, Madrid, ESP
16Hospital Rey Juan Carlos, Móstoles, Spain
17Hospital Gomez Ulla, Madrid, Spain
18Hospital Universitario Quirónsalud Madrid, Madrid, Spain
19Hospital de Villalva, villalba, Spain
20Hospital Universitario Quirón Pozuelo, Madrid, ESP
21Hospital de Mostoles, Mostoles, Spain
22Hospital Universitario del Henares, Madrid, Spain
23MD Anderson Cancer Center, Madrid, ESP
24SERMAS, MAdrid, Spain
25Hospital Universitario Infanta Elena, Madrid, Spain
26Hospital de Sureste, Arganda, Spain
27Hospital Universitario Madrid Sanchinarro, Madrid, Spain
28Hospital del Tajo, Madrid, Spain
29Departament of Hematology, Hospital General Universitario Gregorio Marañón, Gregorio Marañon Health Research Institute, Madrid, Spain
30Hospital Principes de Asturias, Madrid, Spain

*signifies non-member of ASH